Switzerland: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

Revision Of The Therapeutic Products Act (TPA): Increased Medication Safety And Advanced Therapy Medicinal Products

On 3 September 2025, the Federal Council published the dispatch regarding the partial revision of the Therapeutic Products Act (TPA) to be submitted to Parliament.

Switzerland Healthcare

BK

Bär & Karrer

Healthcare: Medical Devices 2025

Switzerland's 2025 healthcare law outlines a complex regulatory framework for medical devices, pharmaceuticals, cosmetics, biocides, and emerging technologies like AI and mHealth.

Switzerland Healthcare

BK

Bär & Karrer

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

On March 21, 2025, the Swiss parliament has adopted a new Cost Containment Package ("CCP2") in response to the continuing rise of healthcare costs...

Switzerland Healthcare

BK

Bär & Karrer

Swiss Federal Supreme Court Prohibits The Use Of Animal Species Names For Plant-Based Meat Substitutes

Switzerland Healthcare

LS

Lenz & Staehelin

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics On Debt Financing With Hercules Capital, Inc.

Switzerland Healthcare

KC

Kellerhals Carrard

Patients' Rights And Artificial Intelligence In Switzerland

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Five Years Of Switzerland's Revised Integrity, Transparency And Discounts Framework: Current Status And Emerging Enforcement Trends

Switzerland Healthcare

BK

Bär & Karrer

Pharmaceutical Advertising 2025

Switzerland Healthcare

BK

Bär & Karrer

Managing Health Data In Switzerland: Navigating Cross-Border CH/EU Challenges

Switzerland Healthcare

BK

Bär & Karrer

Women @ RopesTalk: Conversation With Laura Berner, TRex Bio (Podcast)

Switzerland Healthcare

RG

Ropes & Gray LLP

Switzerland Revises Its Rules For Genetic Testing

Switzerland Healthcare

M

MME

Venture Capital Comparative Guide

Switzerland Commercial

BK

Bär & Karrer

CONVINUS Global Mobility Alert - Week 35.2025

Worldwide Immigration

C

CONVINUS

NEWSLETTER Du 14 Juillet Au 25 Juillet 2025 | N° 109

Switzerland Criminal

MB

Monfrini Bitton Klein

NEWSLETTER Du 23 Juin Au 11 Juillet 2025 | N° 108

Switzerland Criminal

MB

Monfrini Bitton Klein

NEWSLETTER Du 26 Mai Au 6 Juin 2025 | N° 106

Switzerland Criminal

MB

Monfrini Bitton Klein

See more

Food and Drugs Law

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

A Turning Point For Fiduciary Accountability: PBM-Owned Rebate Aggregators In The Spotlight

In 2025, federal scrutiny of Pharmacy Benefit Managers (PBMs) has reached a level not seen before. What was once tolerated as opaque and self-serving practices is now the subject of a coordinated...

Switzerland Accounting

BI

Buchanan Ingersoll & Rooney PC

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

On March 21, 2025, the Swiss parliament has adopted a new Cost Containment Package ("CCP2") in response to the continuing rise of healthcare costs...

Switzerland Healthcare

BK

Bär & Karrer

Swiss Federal Supreme Court Prohibits The Use Of Animal Species Names For Plant-Based Meat Substitutes

Switzerland Healthcare

LS

Lenz & Staehelin

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Panel Discussion: Supply Chain Disputes

Switzerland Litigation

BK

Bär & Karrer

"Burek King" Fails Against "BURGER KING" – The Federal Administrative Court Confirms Risk Of Confusion

M

MME

Life Sciences 2024

Switzerland Healthcare

BK

Bär & Karrer

See more

Life Sciences, Biotechnology & Nanotechnology

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

Revision Of The Therapeutic Products Act (TPA): Increased Medication Safety And Advanced Therapy Medicinal Products

On 3 September 2025, the Federal Council published the dispatch regarding the partial revision of the Therapeutic Products Act (TPA) to be submitted to Parliament.

Switzerland Healthcare

BK

Bär & Karrer

Healthcare: Medical Devices 2025

Switzerland's 2025 healthcare law outlines a complex regulatory framework for medical devices, pharmaceuticals, cosmetics, biocides, and emerging technologies like AI and mHealth.

Switzerland Healthcare

BK

Bär & Karrer

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics On Debt Financing With Hercules Capital, Inc.

Switzerland Healthcare

KC

Kellerhals Carrard

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Five Years Of Switzerland's Revised Integrity, Transparency And Discounts Framework: Current Status And Emerging Enforcement Trends

Switzerland Healthcare

BK

Bär & Karrer

Pharmaceutical Advertising 2025

Switzerland Healthcare

BK

Bär & Karrer

See more

Healthcare

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

Revision Of The Therapeutic Products Act (TPA): Increased Medication Safety And Advanced Therapy Medicinal Products

On 3 September 2025, the Federal Council published the dispatch regarding the partial revision of the Therapeutic Products Act (TPA) to be submitted to Parliament.

Switzerland Healthcare

BK

Bär & Karrer

A Turning Point For Fiduciary Accountability: PBM-Owned Rebate Aggregators In The Spotlight

In 2025, federal scrutiny of Pharmacy Benefit Managers (PBMs) has reached a level not seen before. What was once tolerated as opaque and self-serving practices is now the subject of a coordinated...

Switzerland Accounting

BI

Buchanan Ingersoll & Rooney PC

Healthcare: Medical Devices 2025

Switzerland Healthcare

BK

Bär & Karrer

Compulsory Health Insurance: Is An Exemption Possible?

Switzerland Insurance

VA

Vischer AG

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

Switzerland Healthcare

BK

Bär & Karrer

First Aid Kit At Work In Switzerland: What Employers Need To Know

Switzerland Employment

M

MME

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Patients' Rights And Artificial Intelligence In Switzerland

Switzerland Healthcare

BK

Bär & Karrer

See more

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More